Ro48-8684 is a water-soluble benzodiazepine derivative developed by Hoffman-LaRoche in the 1990s which was designed along with Ro48-6791 as an improved replacement for midazolam but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.
This page contains content from the copyrighted Wikipedia article "Ro48-8684"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
